Literature DB >> 22030394

Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.

Weixun Wang1.   

Abstract

Factor XIIIa-catalyzed ε-(γ-glutamyl)-lysyl bonds between glutamine and lysine residues on fibrin α and γ chains stabilize the fibrin clot and protect it from mechanical and proteolytic damage. The cross-linking of γ chains is known to involve the reciprocal linkages between Gln(398) and Lys(406). In α chains, however, the respective lysine and glutamine partners remain largely unknown. Traditional biochemical approaches have only identified the possible lysine donor and glutamine acceptor sites but have failed to define the respective relationships between them. Here, a differential mass spectrometry method was implemented to characterize cross-linked α chain peptides originating from native fibrin. Tryptic digests of fibrin that underwent differential cross-linking conditions were analyzed by high resolution Fourier transform mass spectrometry. Differential intensities associated with monoisotopic masses of cross-linked peptides were selected for further characterization. A fit-for-purpose algorithm was developed to assign cross-linked peptide pairs of fibrin α chains to the monoisotopic masses relying on accurate mass measurement as the primary criterion for identification. Equipped with hypothesized sequences, tandem mass spectrometry was then used to confirm the identities of the cross-linked peptides. In addition to the reciprocal cross-links between Gln(398) and Lys(406) on the γ chains of fibrin (the positive control of the study), nine specific cross-links (Gln(223)-Lys(508), Gln(223)-Lys(539), Gln(237)-Lys(418), Gln(237)-Lys(508), Gln(237)-Lys(539), Gln(237)-Lys(556), Gln(366)-Lys(539), Gln(563)-Lys(539), and Gln(563)-Lys(601)) on the α chains of fibrin were newly identified. These findings provide novel structural details with respect to the α chain cross-linking compared with earlier efforts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030394      PMCID: PMC3248016          DOI: 10.1074/jbc.M111.297119

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Substitution of the human αC region with the analogous chicken domain generates a fibrinogen with severely impaired lateral aggregation: fibrin monomers assemble into protofibrils but protofibrils do not assemble into fibers.

Authors:  Lifang Ping; Lihong Huang; Barbara Cardinali; Aldo Profumo; Oleg V Gorkun; Susan T Lord
Journal:  Biochemistry       Date:  2011-09-27       Impact factor: 3.162

2.  Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.

Authors:  Rustem I Litvinov; Sergiy Yakovlev; Galina Tsurupa; Oleg V Gorkun; Leonid Medved; John W Weisel
Journal:  Biochemistry       Date:  2007-07-13       Impact factor: 3.162

3.  The development of assays for the detection of fibrin(ogen)olysis based on COOH-terminal A alpha chain epitopes.

Authors:  J H Sobel; H Q Wu; R E Canfield
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

Review 4.  Analysis of intact protein isoforms by mass spectrometry.

Authors:  Jeremiah D Tipton; John C Tran; Adam D Catherman; Dorothy R Ahlf; Kenneth R Durbin; Neil L Kelleher
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

5.  Human fibrinogen heterogeneities: determination of the major Aalpha chain derivatives in blood.

Authors:  D K Galanakis; M W Mosesson
Journal:  Thromb Res       Date:  1983-08-01       Impact factor: 3.944

6.  Structure, stability, and interaction of fibrin αC-domain polymers.

Authors:  Galina Tsurupa; Ariza Mahid; Yuri Veklich; John W Weisel; Leonid Medved
Journal:  Biochemistry       Date:  2011-08-24       Impact factor: 3.162

7.  Structure, stability, and interaction of the fibrin(ogen) alphaC-domains.

Authors:  Galina Tsurupa; Roy R Hantgan; Robert A Burton; Igor Pechik; Nico Tjandra; Leonid Medved
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

8.  Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry.

Authors:  Cloud P Paweletz; Matthew C Wiener; Andrey Y Bondarenko; Nathan A Yates; Qinghua Song; Andy Liaw; Anita Y H Lee; Brandon T Hunt; Ernst S Henle; Fanyu Meng; Holly Funk Sleph; Marie Holahan; Sethu Sankaranarayanan; Adam J Simon; Robert E Settlage; Jeffrey R Sachs; Mark Shearman; Alan B Sachs; Jacquelynn J Cook; Ronald C Hendrickson
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

9.  Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.

Authors:  S Kimura; N Aoki
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

10.  A large-scale method to measure absolute protein phosphorylation stoichiometries.

Authors:  Ronghu Wu; Wilhelm Haas; Noah Dephoure; Edward L Huttlin; Bo Zhai; Mathew E Sowa; Steven P Gygi
Journal:  Nat Methods       Date:  2011-07-03       Impact factor: 28.547

View more
  8 in total

1.  HPLC-free method of synthesis of isotopically labeled deoxyfructosylated peptides.

Authors:  Monika Kijewska; Michalina Zawadzka; Karolina Włodarczyk; Piotr Stefanowicz
Journal:  Anal Bioanal Chem       Date:  2022-03-22       Impact factor: 4.142

2.  Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).

Authors:  Kelly Njine Mouapi; Lucille J Wagner; Chad A Stephens; Mohammed M Hindi; Daniel W Wilkey; Michael L Merchant; Muriel C Maurer
Journal:  Thromb Haemost       Date:  2019-05-05       Impact factor: 5.249

3.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113

4.  Impact of fibrinogen carbamylation on fibrin clot formation and stability.

Authors:  Veronika Binder; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Carsten Scavenius; Endy Spriet; Anne Karin Nyhaug; Helen M Roberts; Iain L C Chapple; Annelie Hellvard; Nicolas Delaleu; Piotr Mydel
Journal:  Thromb Haemost       Date:  2017-04-06       Impact factor: 5.249

Review 5.  Biophysical Mechanisms Mediating Fibrin Fiber Lysis.

Authors:  Nathan E Hudson
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

6.  Engineered isopeptide bond stabilized fibrin inspired nanoscale peptide based sealants for efficient blood clotting.

Authors:  Snehasish Ghosh; Sanchita Mukherjee; Chiranjit Dutta; Kasturee Chakraborty; Paramita Gayen; Somnath Jan; Dhananjay Bhattacharyya; Rituparna Sinha Roy
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

Review 7.  Fibrinogen αC domain: Its importance in physiopathology.

Authors:  Jeannette Soria; Shahsoltan Mirshahi; Sam Qiumars Mirshahi; Remi Varin; Linda L Pritchard; Claudine Soria; Massoud Mirshahi
Journal:  Res Pract Thromb Haemost       Date:  2019-02-15

8.  Fibrinogen Glycation and Presence of Glucose Impair Fibrin Polymerization-An In Vitro Study of Isolated Fibrinogen and Plasma from Patients with Diabetes Mellitus.

Authors:  Boguslawa Luzak; Magdalena Boncler; Marcin Kosmalski; Ewelina Mnich; Lidia Stanczyk; Tomasz Przygodzki; Cezary Watala
Journal:  Biomolecules       Date:  2020-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.